Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › Research › peer-review
Measurement of Parameters of Neutron Radiation on the Accelerator-Based Epithermal Neutron Source. / Bikchurina, M. I.; Bykov, T. A.; Kasatov, D. A. et al.
27th Russian Particle Accelerator Conference, RuPAC 2021. ed. / Maksim Kuzin; Volker R W Schaa. CERN, 2021. p. 337-339 TUPSB53 (CERN-Proceedings; Vol. 2021-September).Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › Research › peer-review
}
TY - GEN
T1 - Measurement of Parameters of Neutron Radiation on the Accelerator-Based Epithermal Neutron Source
AU - Bikchurina, M. I.
AU - Bykov, T. A.
AU - Kasatov, D. A.
AU - Kolesnikov, Ia A.
AU - Shchudlo, I. M.
AU - Taskaev, S. Yu
N1 - Funding Information: Work supported by grant from the Russian Science Foundation (grant no. 19-72-30005), the Budker Institute of Nuclear Physics and the Novosibirsk State University Publisher Copyright: © 27th Russian Particle Accelerator Conference, RuPAC 2021. All rights reserved.
PY - 2021
Y1 - 2021
N2 - Treatment of oncological diseases using Boron Neutron Capture Therapy (BNCT) is an important issue of our time. Cancer cells accumulate a boron-containing drug, after which they are irradiated with a beam of epithermal neutrons, a nuclear reaction 10B(n,α)7Li occurs, and the products of a nuclear reaction destroy these cells. In BNCT, it is generally accepted that the total dose of ionizing radiation consists of four components: boron dose, dose from fast neutrons, dose from thermal neutrons, and dose of gamma radiation. Dose values and their ratio strongly depend on the neutron flux; therefore, the measurement of the neutron flux (yield) is an urgent task. In this work, the neutron yield was measured by the activation of the target with the radioactive isotope beryllium-7, which is formed in the reaction of neutron generation 7Li(p,n)7Be. It was found that the neutron yield from a specifically manufactured lithium target is in good agreement with the calculated one, which is important for planning therapy.
AB - Treatment of oncological diseases using Boron Neutron Capture Therapy (BNCT) is an important issue of our time. Cancer cells accumulate a boron-containing drug, after which they are irradiated with a beam of epithermal neutrons, a nuclear reaction 10B(n,α)7Li occurs, and the products of a nuclear reaction destroy these cells. In BNCT, it is generally accepted that the total dose of ionizing radiation consists of four components: boron dose, dose from fast neutrons, dose from thermal neutrons, and dose of gamma radiation. Dose values and their ratio strongly depend on the neutron flux; therefore, the measurement of the neutron flux (yield) is an urgent task. In this work, the neutron yield was measured by the activation of the target with the radioactive isotope beryllium-7, which is formed in the reaction of neutron generation 7Li(p,n)7Be. It was found that the neutron yield from a specifically manufactured lithium target is in good agreement with the calculated one, which is important for planning therapy.
UR - http://www.scopus.com/inward/record.url?scp=85130362889&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/a9eded02-707b-394c-9fd8-20201e838637/
U2 - 10.18429/JACoW-RuPAC2021-TUPSB53
DO - 10.18429/JACoW-RuPAC2021-TUPSB53
M3 - Conference contribution
AN - SCOPUS:85130362889
SN - 9783954502400
T3 - CERN-Proceedings
SP - 337
EP - 339
BT - 27th Russian Particle Accelerator Conference, RuPAC 2021
A2 - Kuzin, Maksim
A2 - Schaa, Volker R W
PB - CERN
T2 - 27th Russian Particle Accelerator Conference, RuPAC 2021
Y2 - 27 September 2021 through 1 October 2021
ER -
ID: 36162001